BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 37759960)

  • 1. Lactate: A Theranostic Biomarker for Metabolic Psychiatry?
    Caddye E; Pineau J; Reyniers J; Ronen I; Colasanti A
    Antioxidants (Basel); 2023 Aug; 12(9):. PubMed ID: 37759960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders.
    Morella IM; Brambilla R; Morè L
    Neurosci Biobehav Rev; 2022 Nov; 142():104892. PubMed ID: 36181925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies.
    Pruett BS; Meador-Woodruff JH
    Schizophr Res; 2020 Sep; 223():29-42. PubMed ID: 32958361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Evaluation of a Lactate Microbiosensor: Toward Multianalyte Monitoring of Neurometabolic Markers In Vivo in the Brain.
    Fernandes E; Ledo A; Barbosa RM
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.
    Kim Y; Vadodaria KC; Lenkei Z; Kato T; Gage FH; Marchetto MC; Santos R
    Antioxid Redox Signal; 2019 Aug; 31(4):275-317. PubMed ID: 30585734
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.
    Machado-Vieira R; Zanetti MV; Otaduy MC; De Sousa RT; Soeiro-de-Souza MG; Costa AC; Carvalho AF; Leite CC; Busatto GF; Zarate CA; Gattaz WF
    J Clin Psychopharmacol; 2017 Feb; 37(1):40-45. PubMed ID: 27902528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.
    Magistretti PJ; Pellerin L
    Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1155-63. PubMed ID: 10466143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early label-free analysis of mitochondrial redox states by Raman spectroscopy predicts septic outcomes.
    Wu M; Pu K; Jiang T; Zhai Q; Ma Z; Ma H; Xu F; Zhang Z; Wang Q
    J Adv Res; 2021 Feb; 28():209-219. PubMed ID: 33364057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting-State Functional Connectivity-Based Biomarkers and Functional MRI-Based Neurofeedback for Psychiatric Disorders: A Challenge for Developing Theranostic Biomarkers.
    Yamada T; Hashimoto RI; Yahata N; Ichikawa N; Yoshihara Y; Okamoto Y; Kato N; Takahashi H; Kawato M
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):769-781. PubMed ID: 28977523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neurometabolic Basis of Mood Instability: The Parvalbumin Interneuron Link-A Systematic Review and Meta-Analysis.
    Pinna A; Colasanti A
    Front Pharmacol; 2021; 12():689473. PubMed ID: 34616292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of MRS-quantified brain tissue lactate level in identifying children with mitochondrial disorders.
    Lunsing RJ; Strating K; de Koning TJ; Sijens PE
    Eur Radiol; 2017 Mar; 27(3):976-984. PubMed ID: 27271921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurometabolism in human epilepsy.
    Pan JW; Williamson A; Cavus I; Hetherington HP; Zaveri H; Petroff OA; Spencer DD
    Epilepsia; 2008; 49 Suppl 3(0 3):31-41. PubMed ID: 18304254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and psychiatric disorders.
    Jou SH; Chiu NY; Liu CS
    Chang Gung Med J; 2009; 32(4):370-9. PubMed ID: 19664343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
    Millichap LE; Damiani E; Tiano L; Hargreaves IP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral biomarkers of mitochondrial dysfunction in adolescents with bipolar disorder.
    Jeong H; Dimick MK; Sultan A; Duong A; Park SS; El Soufi El Sabbagh D; Goldstein BI; Andreazza AC
    J Psychiatr Res; 2020 Apr; 123():187-193. PubMed ID: 32078836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention.
    Rossetti AC; Paladini MS; Riva MA; Molteni R
    Pharmacol Ther; 2020 Jun; 210():107520. PubMed ID: 32165136
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.